Ac-LEVD-CHO (trifluoroacetate salt) (Synonyms: Ac-Leu-Glu-Val-Asp-CHO, Caspase-4 Inhibitor I) |
| Catalog No.GC42709 |
Ac-LEVD-CHO is a caspase-4 inhibitor.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Ac-LEVD-CHO is a caspase-4 inhibitor.[1] It inhibits IL-1α expression and secretion and caspase-4 activation induced by the T. denticola periodontal pathogen surface protein Td92 in human gingival fibroblasts when used at a concentration of 30 μM. Ac-LEVD-CHO (10 μM) also reduces apoptosis induced by expression of the dominant negative adenoviral RNA-dependent protein kinase (Ad-δ6PKR) in A549 and PC3 cancer cells.[2]
Reference:
[1]. Jun, H.-K., Jung, Y.-J., An, S.-J., et al. Caspase-4 activation by a bacterial surface protein is mediated by cathepsin G in human gingival fibroblasts. Cell Death Differ. 25(2), 380-391 (2018).
[2]. Pataer, A., Swisher, S.G., Roth, J.A., et al. Inhibition of RNA-dependent protein kinase (PKR) leads to cancer cell death and increases chemosensitivity. Cancer Biol. Ther. 8(3), 245-252 (2009).
Average Rating: 5 (Based on Reviews and 5 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *